The Journal of Experimental Medicine
  Home | Help | Feedback | Subscriptions | Archive | Search | Table of Contents

Published online
doi:10.1084/jem.20090782
The Journal of Experimental Medicine, Vol. 206, No. 11, 2429-2440
The Rockefeller University Press, 0022-1007 $30.00
© Hu et al.
This Article
Right arrow Full Text
Right arrow Full Text (PDF, 4508K)
Right arrow PDF+supp data (7000K)
Right arrow PPT slides of all figures
Right arrow Supplemental Material
Right arrow Alert me when this article is cited
Right arrow Citation Map
Services
Right arrow Email this article
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new content in the JEM
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via CrossRef
Google Scholar
Right arrow Articles by Hu, C.-C. A.
Right arrow Articles by Ploegh, H. L.
PubMed
Right arrow PubMed Citation
Right arrow Articles by Hu, C.-C. A.
Right arrow Articles by Ploegh, H. L.
Social Bookmarking
 Add to CiteULike   Add to Complore   Add to Connotea   Add to Del.icio.us   Add to Digg   Add to Facebook   Add to Reddit   Add to Technorati   Add to Twitter  
What's this?

Article

Subtilase cytotoxin cleaves newly synthesized BiP and blocks antibody secretion in B lymphocytes

Chih-Chi Andrew Hu1, Stephanie K. Dougan1, Sebastian Virreira Winter1, Adrienne W. Paton2, James C. Paton2, and Hidde L. Ploegh1

1 Whitehead Institute for Biomedical Research, Cambridge, MA 02142
2 Research Centre for Infectious Diseases, School of Molecular and Biomedical Science, University of Adelaide, SA 5005, Australia

CORRESPONDENCE Hidde L. Ploegh: ploegh{at}wi.mit.edu

Shiga-toxigenic Escherichia coli (STEC) use subtilase cytotoxin (SubAB) to interfere with adaptive immunity. Its inhibition of immunoglobulin secretion is both rapid and profound. SubAB favors cleavage of the newly synthesized immunoglobulin heavy chain–binding protein (BiP) to yield a C-terminal fragment that contains BiP’s substrate-binding domain. In the absence of its regulatory nucleotide-binding domain, the SubAB-cleaved C-terminal BiP fragment remains tightly bound to newly synthesized immunoglobulin light chains, resulting in retention of light chains in the endoplasmic reticulum (ER). Immunoglobulins are thus detained in the ER, making impossible the secretion of antibodies by SubAB-treated B cells. The inhibitory effect of SubAB is highly specific for antibody secretion, because other secretory proteins such as IL-6 are released normally from SubAB-treated B cells. Although SubAB also causes BiP cleavage in HepG2 hepatoma cells, (glyco)protein secretion continues unabated in SubAB-exposed HepG2 cells. This specific block in antibody secretion is a novel means of immune evasion for STEC. The differential cleavage of newly synthesized versus "aged" BiP by SubAB in the ER provides insight into the architecture of the ER compartments involved.


Abbreviations used: BiP, immunoglobulin heavy chain–binding protein; HUS, hemolytic uremic syndrome; NBD, nucleotide-binding domain; PDI, protein disulfide isomerase; SBD, substrate-binding domain; STEC, Shiga-toxigenic Escherichia coli; SubAB, subtilase cytotoxin; UPR, unfolded protein response.

© 2009 Hu et al.
This article is distributed under the terms of an Attribution–Noncommercial–Share Alike–No Mirror Sites license for the first six months after the publication date (see http://www.jem.org/misc/terms.shtml). After six months it is available under a Creative Commons License (Attribution–Noncommercial–Share Alike 3.0 Unported license, as described at http://creativecommons.org/licenses/by-nc-sa/3.0/).


Add to CiteULike CiteULike   Add to Complore Complore   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Facebook Facebook   Add to Reddit Reddit   Add to Technorati Technorati   Add to Twitter Twitter    What's this?




  Home | Help | Feedback | Subscriptions | Archive | Search
TABLE OF CONTENTS